2+ Billion Affected by NAFLD Worldwide – Don't Wait for Advanced Stages

Liver disease affects over 1.5 billion people worldwide, with 2 million deaths annually. In the US alone, 100,000+ patients need liver transplants but only 8,000 donors are available yearly - a devastating 12:1 ratio. Early detection and continuous monitoring through tools like LiverTracker can prevent 60% of liver-related deaths by catching deterioration before it becomes irreversible.

Every day, 17 Americans die waiting for liver transplants due to the critical organ shortage. LiverTracker helps patients optimize their health while waiting, track MELD scores that determine transplant priority, and provides healthcare teams with comprehensive data to make life-saving decisions faster.

With only 1 donor available for every 12 patients needing liver transplants globally, prevention and early intervention are literally matters of life and death. LiverTracker enables proactive monitoring that can slow disease progression, potentially keeping patients off transplant lists or improving their survival while waiting.

MELD scores (6-40 scale) determine transplant priority - patients with MELD 35+ have 90-day mortality rates exceeding 50%. Our platform automatically calculates MELD scores from lab uploads, tracks trends, and alerts patients to critical changes, ensuring they receive appropriate medical attention and transplant consideration at the right time.

Liver disease is often "silent" until advanced stages. Our AI-powered analysis of routine lab work can detect early warning signs that patients and even some healthcare providers might miss, potentially adding years to lives through early intervention and lifestyle changes.

With liver specialists scarce (1 hepatologist per 70,000 liver patients), our platform democratizes access to expert-level monitoring. Patients can track critical metrics between appointments, share comprehensive data with any healthcare provider, and receive AI-powered insights typically only available at major medical centers.

Liver disease costs the US healthcare system $32 billion annually, with 80% spent on end-stage complications. Early tracking and intervention can reduce hospitalizations by 40% and prevent costly emergency interventions, while our platform costs less than a single ER visit.

Sudden changes in liver function can indicate life-threatening complications like hepatic encephalopathy or variceal bleeding. Our trend analysis and alert system can detect deterioration weeks before symptoms appear, enabling preventive treatment that can avoid ICU admissions and save lives.

Child-Pugh scores predict survival rates and guide treatment decisions - Class C patients have 45% one-year mortality. Our platform automatically calculates these complex scores from simple lab uploads, making this life-saving assessment tool available to any patient with basic lab work, not just those at specialized centers.

Liver patients often see multiple specialists (hepatologist, cardiologist, surgeon, primary care), leading to fragmented care and missed critical changes. Our secure sharing system ensures all providers have access to complete, up-to-date liver function data, improving coordination and potentially preventing the medical errors that contribute to the 44,000 annual liver disease deaths in the US.